Literature DB >> 9145872

Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.

S Bajaksouzian1, M A Visalli, M R Jacobs, P C Appelbaum.   

Abstract

A total of 101 Acinetobacter genospecies (77 Acinetobacter baumannii strains and 24 non-A. baumannii strains) were tested for their susceptibilities to levofloxacin, ofloxacin, and ciprofloxacin and for synergy between the quinolones and amikacin by checkerboard titration and time-kill analyses. The MICs at which 50% of the isolates are inhibited (MIC50)/MIC90s for the 101 strains were as follows (in micrograms per milliliter): levofloxacin, 0.25/16.0; ofloxacin, 0.5/32.0; ciprofloxacin, 0.25/> 64.0; and amikacin, 1.0/> 32.0. At empiric breakpoints of < or = 2.0 microg/ml, 61% of the strains were susceptible to all three quinolones. At a breakpoint of < or = 16.0 microg/ml, 84% of the strains were susceptible to amikacin. Checkerboard titrations yielded synergistic fractional inhibitory concentration (FIC) indices (< or = 0.5) for one strain with levofloxacin and amikacin and for two strains with ofloxacin and amikacin. Indices of > 0.5 to 1.0 were seen for 57, 54, and 55 strains with levofloxacin plus amikacin, ofloxacin plus amikacin, and ciprofloxacin plus amikacin, respectively, and indices of > 1.0 in 43, 45, and 46 strains, respectively, were found with the above three combinations. No strains yielded antagonistic FIC indices (> 4.0). Most FIC results of > 1.0 occurred in strains for which the quinolone MICs were > 2.0 microg/ml and for which the amikacin MICs were > or = 32.0 microg/ml. By contrast, synergy (defined as > or = 2 log10 decrease compared to the more active compound alone by time-kill analysis) was found in all seven strains tested for which the quinolone MICs were < or = 2.0 microg/ml. For eight other strains for which the quinolone MICs were > 2.0 microg/ml as determined by time-kill analysis, quinolone and amikacin concentrations in combination were usually too high to permit clinical use. Time-kill analysis was found to be more sensitive in detecting synergy than was the checkerboard method.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145872      PMCID: PMC163853     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Cross resistance to ciprofloxacin and other antimicrobial agents among clinical isolates of Acinetobacter calcoaceticus biovar anitratus.

Authors:  I Shalit; M Dan; R Gutman; A Gorea; S A Berger
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

2.  Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.

Authors:  S Bajaksouzian; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  In vitro activity of S-ofloxacin.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

Review 4.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.

Authors:  A von Graevenitz; C Bucher
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

6.  Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus.

Authors:  E Bergogne-Berezin; M L Joly-Guillou
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

7.  In vitro susceptibility of Acinetobacter species to various antimicrobial agents.

Authors:  K V Rolston; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

8.  Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.

Authors:  P C Appelbaum; S K Spangler; L Sollenberger
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

9.  Comparative in-vitro activity of ciprofloxacin against non-fermenters.

Authors:  M O Husson; D Izard; L Bouillet; H Leclerc
Journal:  J Antimicrob Chemother       Date:  1985-04       Impact factor: 5.790

10.  Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.

Authors:  P C Appelbaum; S K Spangler; T Tamarree
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

View more
  25 in total

1.  Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are high.

Authors:  C L Clark; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Synthesis and antibacterial activity of some heterocyclic chalcone analogues alone and in combination with antibiotics.

Authors:  Thanh-Dao Tran; Thi-Thao-Nhu Nguyen; Tuong-Ha Do; Thi-Ngoc-Phuong Huynh; Cat-Dong Tran; Khac-Minh Thai
Journal:  Molecules       Date:  2012-06-01       Impact factor: 4.411

3.  Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.

Authors:  Gani Orhan; Aysen Bayram; Yasemin Zer; Iclal Balci
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  Glenn A Pankuch; Gengrong Lin; Harald Seifert; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

5.  Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.

Authors:  Kim Credito; Gengrong Lin; Laura Koeth; Michael A Sturgess; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

6.  Hydroxyl radicals are involved in cell killing by the bacterial topoisomerase I cleavage complex.

Authors:  I-Fen Liu; Thirunavukkarasu Annamalai; Jeanette H Sutherland; Yuk-Ching Tse-Dinh
Journal:  J Bacteriol       Date:  2009-06-12       Impact factor: 3.490

7.  Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.

Authors:  M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

8.  Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.

Authors:  B E Domaracki; A M Evans; R A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

9.  Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species.

Authors:  E Gradelski; L Valera; D Bonner; J Fung-Tomc
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Cheng-Yi Chen; Wen-Hwei Chen; Chong-Jen Yu; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.